290 related articles for article (PubMed ID: 36243357)
1. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
[TBL] [Abstract][Full Text] [Related]
2. Modulation of mitochondrial dysfunction in neurodegenerative diseases via activation of nuclear factor erythroid-2-related factor 2 by food-derived compounds.
Denzer I; Münch G; Friedland K
Pharmacol Res; 2016 Jan; 103():80-94. PubMed ID: 26626189
[TBL] [Abstract][Full Text] [Related]
3. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
4. Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.
Johnson DA; Johnson JA
Free Radic Biol Med; 2015 Nov; 88(Pt B):253-267. PubMed ID: 26281945
[TBL] [Abstract][Full Text] [Related]
5. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
Dinkova-Kostova AT; Kostov RV; Kazantsev AG
FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
Bahn G; Jo DG
Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
Xiang Y; Song X; Long D
Arch Toxicol; 2024 Mar; 98(3):579-615. PubMed ID: 38265475
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs.
Paladino S; Conte A; Caggiano R; Pierantoni GM; Faraonio R
Cell Physiol Biochem; 2018; 47(5):1951-1976. PubMed ID: 29969760
[TBL] [Abstract][Full Text] [Related]
10. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
[TBL] [Abstract][Full Text] [Related]
11. Role of the Keap1/Nrf2 pathway in neurodegenerative diseases.
Yamazaki H; Tanji K; Wakabayashi K; Matsuura S; Itoh K
Pathol Int; 2015 May; 65(5):210-9. PubMed ID: 25707882
[TBL] [Abstract][Full Text] [Related]
12. NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches.
Sivandzade F; Prasad S; Bhalerao A; Cucullo L
Redox Biol; 2019 Feb; 21():101059. PubMed ID: 30576920
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function.
Esteras N; Dinkova-Kostova AT; Abramov AY
Biol Chem; 2016 May; 397(5):383-400. PubMed ID: 26812787
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular and Neurological Disorders: Protective Role of NRF2.
Sivandzade F; Bhalerao A; Cucullo L
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336872
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
Lee DH; Gold R; Linker RA
Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
18. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
19. Basic Leucine Zipper Protein Nuclear Factor Erythroid 2-related Factor 2 as a Potential Therapeutic Target in Brain Related Disorders.
Goyal A; Gopika S; Agrawal N
Protein Pept Lett; 2022; 29(8):676-691. PubMed ID: 35733308
[TBL] [Abstract][Full Text] [Related]
20. Mitophagy in Alzheimer's Disease and Other Age-Related Neurodegenerative Diseases.
Cai Q; Jeong YY
Cells; 2020 Jan; 9(1):. PubMed ID: 31936292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]